Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- Check2 days agoChange DetectedAdded a site-wide funding/status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoChange DetectedAdded a glossary toggle and updated QC-related labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Standardized capitalization for 'No FEAR Act Data' (replacing 'No FEAR Act data').SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision history updated: Revision v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedLocations section structure updated: added a general Locations section and state entries for Florida, Illinois, New York, and Ohio; removed Florida Locations, Illinois Locations, New York Locations, and Ohio Locations. Revision updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check73 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 with no change to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedFunding-status notice banner removed from the page, eliminating information about potential delays and limited site responses.SummaryDifference0.3%

Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.